American Journal of Neuroradiology 26:2037-2042, September 2005
© 2005 American Society of Neuroradiology
BRAIN
MR Imaging and Proton Spectroscopy of Neuronal Injury in Late-Onset GM2 Gangliosidosis
a From the Departments of Radiology, New York University, New York, NY
b Neurology, New York University, New York, NY
c Rehabilitation Medicine, New York University, New York, NY
Address correspondence to Matilde Inglese, MD, Department of Radiology, New York University, 650 1st Avenue, 6th Floor, New York, NY 10016
BACKGROUND AND PURPOSE: Despite the ubiquity of GM2 gangliosides accumulation in patients with late-onset GM2 gangliosidosis (GM2G), the only clinical MR imagingapparent brain abnormality is profound cerebellar atrophy. The goal of this study was to detect the presence and assess the extent of neuroaxonal injury in the normal-appearing gray and white matter (NAGM and NAWM) of these patients.
METHODS: During a single imaging session, 9 patients with late-onset GM2G and 8 age-matched normal volunteers underwent the following protocol: (1) T1- and T2-weighted and fluid-attenuated inversion recovery MR images, as well as (2) multivoxel proton MR spectroscopy (1H-MR spectroscopy) to quantify the distribution of the N-acetylaspartate (NAA), creatine (Cr), and choline (Cho), were obtained.
RESULTS: The patients NAA levels in the thalamus (6.5 ± 1.9 mmol/L) and NAWM (5.8 ± 2.1 mmol/L) were
40% lower than the controls (P = .003 and P = .005), whereas the Cr and Cho reductions (
30% and
26%) did not reach significance (P values of .06.1). All cerebellar metabolites, especially NAA and Cr, were much (30%90%) lower in the patients, which reflects the atrophy.
CONCLUSION: In late-onset GM2G, NAA decreases are detectable in NAGM and NAWM even absent morphologic (MR imaging) abnormalities. Because the accumulation of GM2 gangliosides can be reduced pharmacologically, 1H-MR spectroscopy might be a sensitive and specific for detecting and quantifying neuroaxonal injury and monitoring response to emerging treatments.
This article has been cited by other articles:
![]() |
L. Vedolin, I.V.D. Schwartz, M. Komlos, A. Schuch, A.C. Puga, L.L.C. Pinto, A.P. Pires, and R. Giugliani Correlation of MR Imaging and MR Spectroscopy Findings with Cognitive Impairment in Mucopolysaccharidosis II AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1029 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. B. Maegawa, T. Stockley, M. Tropak, B. Banwell, S. Blaser, F. Kok, R. Giugliani, D. Mahuran, and J. T.R. Clarke The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported Pediatrics, November 1, 2006; 118(5): e1550 - e1562. [Abstract] [Full Text] [PDF] |
||||

